ClinicalTrials.Veeva

Menu

Examining the Use of a Novel Immersive Motion Tracking Upper Extremity Exercise Program for Acute Hospitalized Patients

NYU Langone Health logo

NYU Langone Health

Status

Not yet enrolling

Conditions

Kidney Transplant
Liver Transplant

Treatments

Device: MoveMend Health

Study type

Interventional

Funder types

Other

Identifiers

NCT06222554
23-01384

Details and patient eligibility

About

The objective of this study is to evaluate the feasibility of the MoveMend Health software program as an integrated supplement to traditional acute care/in-hospital occupational therapy for patients following liver and kidney transplants, as determined by recruitment rates, program completion, intervention adherence, safety incidence, and patient feedback on device/program performance.

Enrollment

30 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • English speaking (software program is currently only available in English)
  • Status post kidney or liver transplant this admission
  • Physician orders for occupational therapy evaluation and treatment
  • Orientation Log > 25
  • Negative for delirium per the Confusion Assessment Method

Exclusion criteria

  • Orthopedic or surgical precautions that limits shoulder range of motion beyond 90 degrees
  • Upper extremity hemiplegia with inability to lift upper extremity against gravity
  • Accommodation code of Intensive Care Unit

Trial design

Primary purpose

Device Feasibility

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

30 participants in 1 patient group

Patients Hospitalized following Kidney or Liver Transplant
Experimental group
Description:
Patients in the study will be introduced to the exercise software program and provided with a demonstration. Measurements will be taken at baseline (post-operation) and at the final study visit. Participants will remain in the study until the end of their hospital stay, typically no longer than 6 months post-operation.
Treatment:
Device: MoveMend Health

Trial contacts and locations

0

Loading...

Central trial contact

Gabrielle Berne

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems